Le Lézard
Classified in: Science and technology
Subject: PDT

UDOO BOLT Brings AMD Ryzentm Embedded V1000 in the Maker World


BOSTON, June 19, 2018 /CNW/ -- The UDOO BOLT is a quantum leap compared to current maker boards. It is almost twice as powerful as the MacBook Pro 13" for a starting price as little as $229. It's the world's first maker board based on the AMD Ryzentm Embedded V1000 SoC, which integrates the transformative AMD "Zen" CPU architecture with the powerhouse AMD "Vega" GPU architecture on a single die and, with a top speed of 3.6 GHz, it is the maker board with the highest CPU clock on Earth. Its GPU unlocks a whole new level of immersive experience, supporting any current AAA game, HDR, Radeon FreeSynctm 2 and, last but not least, video streaming in 4k resolution at 60 fps on four screens at once thanks to four video ports - two USB-C and two HDMI 2.0 which, by the way, are FCC and CE certified. Designed for AI, VR, AR and Computer Vision, it embeds the groundbreaking AMD SenseMI Technology for true machine intelligence. Storage-wise it supports M.2 NVMe, M.2 SSDs, SATA, and USB 3.1, and also mounts a 32 GB eMMC, but if the campaign hits $800,000 the UDOO Team promises a free 64 GB eMMC upgrade.

Link: https://udoo-bolt.udoo.org

For the hardcore makers, the UDOO BOLT also mounts an Arduino-compatible platform, complete with IOs for the CPU and the Arduino onboard. Furthermore, it features Grove connectors for easy tinkering, not to mention the keyboard scan which allows to build combo custom controllers.

The UDOO BOLT runs Windows and Linux and it's plug and play.

Contact: Simona Agostinelli, [email protected], +39-3356188312

 

SOURCE UDOO


These press releases may also interest you

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:42
Reference is made to Akastor ASA's (OSE: AKAST) announcement dated 18 April 2024 on the arbitration award issued in respect of the DRU contracts. Payment of the principal sums awarded, in total USD 108 million (exclusive interest), has now been...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
IonQ , a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ's upcoming Annual...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...



News published on and distributed by: